Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HCYTD H-CYTE	$2.02 -49.5%	$2.02	$2.02 ▼ $77.00	$521K	1.12	103 shs	400 shs
NAOV Nanovibronix	$5.39 -2.7%	$8.99	$5.03 ▼ $162.50	$1.40M	1.83	302,622 shs	32,839 shs
USAQ QHSLab	$0.19	$0.20	$0.08 ▼ $0.47	$2.01M	0.48	19,528 shs	6,350 shs
VTAK Catheter Precision	$3.02 -4.4%	$4.55	$2.49 ▼ $47.31	$1.75M	-0.65	704,064 shs	439,929 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HCYTD H-CYTE	0.00%	0.00%	0.00%	0.00%	0.00%
NAOV Nanovibronix	-12.76%	-25.44%	-45.15%	-53.05%	-91.66%
USAQ QHSLab	+0.53%	+0.53%	-5.00%	-28.30%	+26.67%
VTAK Catheter Precision	-25.65%	-3.86%	-28.31%	-44.93%	-89.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HCYTD H-CYTE	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NAOV Nanovibronix	0.1454 of 5 stars	0.0	3.0	0.0	0.0	0.0	0.0	0.6
USAQ QHSLab	0.3198 of 5 stars	0.0	3.0	0.0	0.0	0.8	1.7	0.0
VTAK Catheter Precision	0.8264 of 5 stars	0.0	3.0	0.0	0.0	2.3	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
HCYTD H-CYTE	N/A	N/A	N/A
NAOV Nanovibronix	N/A	N/A	N/A
USAQ QHSLab	N/A	N/A	N/A
VTAK Catheter Precision	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HCYTD H-CYTE	$1.61M	0.32	N/A	N/A	($31.45) per share	-0.06
NAOV Nanovibronix	$2.56M	0.55	N/A	N/A	$18.38 per share	0.29
USAQ QHSLab	$2.13M	0.94	N/A	N/A	($0.06) per share	-3.17
VTAK Catheter Precision	$420K	4.17	N/A	N/A	$11.30 per share	0.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HCYTD H-CYTE	-$4.80M	N/A	0.00	∞	N/A	-450.40%	N/A	-777.68%	N/A
NAOV Nanovibronix	-$3.70M	-$13.53	N/A	∞	N/A	-210.82%	-54.73%	-38.63%	N/A
USAQ QHSLab	-$260K	-$0.04	N/A	∞	N/A	-15.33%	N/A	-21.37%	N/A
VTAK Catheter Precision	-$16.64M	N/A	0.00	N/A	N/A	-3,150.33%	-193.63%	-72.09%	N/A

Latest HCYTD, USAQ, NAOV, and VTAK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/19/2025	Q2 2025	NAOV Nanovibronix	N/A	-$1.03	N/A	-$1.03	N/A	$0.49 million
5/20/2025	Q1 2025	NAOV Nanovibronix	N/A	-$39.80	N/A	-$3.98	N/A	$1.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HCYTD H-CYTE	N/A	N/A	N/A	N/A	N/A
NAOV Nanovibronix	N/A	N/A	N/A	N/A	N/A
USAQ QHSLab	N/A	N/A	N/A	N/A	N/A
VTAK Catheter Precision	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HCYTD H-CYTE	N/A	0.12	0.12
NAOV Nanovibronix	N/A	0.47	0.22
USAQ QHSLab	N/A	0.16	0.13
VTAK Catheter Precision	0.19	0.44	0.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HCYTD H-CYTE	N/A
NAOV Nanovibronix	16.39%
USAQ QHSLab	N/A
VTAK Catheter Precision	20.34%

Insider Ownership

Company	Insider Ownership
HCYTD H-CYTE	5.24%
NAOV Nanovibronix	6.30%
USAQ QHSLab	74.19%
VTAK Catheter Precision	2.95%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HCYTD H-CYTE	8	258,000	244,000	Not Optionable
NAOV Nanovibronix	20	260,000	242,000	Not Optionable
USAQ QHSLab	5	10.59 million	2.73 million	Not Optionable
VTAK Catheter Precision	14	580,000	563,000	N/A

HCYTD, USAQ, NAOV, and VTAK Headlines

Recent News About These Companies

Why Did Catheter Precision Stock Soar 49% Today?

August 19 at 7:38 AM | msn.com

Why Is Catheter Precision Stock (VTAK) Up 70% Today?

August 19 at 7:38 AM | msn.com

Catheter Precision Receives Approval for LockeT in the United Kingdom

August 18 at 9:05 AM | finance.yahoo.com

Catheter Precision Implements 1-for-19 Reverse Stock Split

August 15, 2025 | tipranks.com

Catheter Precision announces effectiveness of 1-for-19 reverse stock split

August 15, 2025 | msn.com

Catheter Precision, Inc. Announces Effective Date of 1-for-19 Reverse Stock Split

August 15, 2025 | quiverquant.comQ

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

August 15, 2025 | globenewswire.com

Catheter Precision announces first LockeT cases completed in Germany

August 14, 2025 | msn.com

First LockeT Cases Completed in Germany

August 13, 2025 | finance.yahoo.com

Catheter Precision, Inc. Reports Results of Operations for Second Quarter 2025

August 12, 2025 | finance.yahoo.com

Milestone Achievement for Hospital Using Catheter Precision’s VIVO System

August 7, 2025 | finance.yahoo.com

Catheter Precision Approves Reverse Stock Split Plan

July 30, 2025 | theglobeandmail.com

Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France

July 7, 2025 | finance.yahoo.com

Catheter Precision, Inc. and Chelak iECG, Inc. Launch Joint Venture Kardionav for Advancements in Ventricular Tachycardia Ablation Technology - Nasdaq

July 2, 2025 | nasdaq.com

Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform

June 30, 2025 | finance.yahoo.com

Catheter Precision, Inc. and Chelak iECG, Inc. Launch Joint Venture Kardionav for Advancements in Ventricular Tachycardia Ablation Technology

June 30, 2025 | quiverquant.comQ

Catheter Precision Inc News (VTAK) - Investing.com

June 28, 2025 | investing.com

Catheter Precision, Inc. Addresses Increased Trading Activity in Common Stock

June 12, 2025 | quiverquant.comQ

Catheter Precision, Inc. Comments on Recent Market Activity

June 12, 2025 | globenewswire.com

Catheter Precision (VTAK) Reports Key Progress for the LockeT Product

June 12, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCYTD, USAQ, NAOV, and VTAK Company Descriptions

H-CYTE OTCMKTS:HCYTD

$2.02 -1.98 (-49.50%)

As of 07/11/2022

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Nanovibronix NASDAQ:NAOV

$5.38 -0.16 (-2.89%)

As of 04:00 PM Eastern

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

QHSLab OTCMKTS:USAQ

$0.19 0.00 (0.00%)

As of 11:43 AM Eastern

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

Catheter Precision NYSEAMERICAN:VTAK

$3.02 -0.14 (-4.43%)

Closing price 04:00 PM Eastern

Extended Trading

$3.04 +0.02 (+0.79%)

As of 04:20 PM Eastern

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time